DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
0.780
+0.024 (3.23%)
At close: Nov 4, 2024, 4:00 PM
0.750
-0.030 (-3.85%)
After-hours: Nov 4, 2024, 6:36 PM EST
DBV Technologies Employees
As of December 31, 2023, DBV Technologies had 105 total employees, including 104 full-time and 1 part-time employees. The number of employees increased by 19 or 22.09% compared to the previous year.
Employees
105
Change (1Y)
19
Growth (1Y)
22.09%
Revenue / Employee
$131,562
Profits / Employee
-$841,743
Market Cap
80.25M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InterCure | 270 |
Metagenomi | 236 |
RAPT Therapeutics | 131 |
IO Biotech | 68 |
Aerovate Therapeutics | 51 |
Ovid Therapeutics | 40 |
MediciNova | 13 |
Monopar Therapeutics | 10 |
DBVT News
- 13 days ago - DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe - GlobeNewsWire
- 17 days ago - DBV Technologies to Participate in Upcoming ACAAI 2024 Congress - GlobeNewsWire
- 6 weeks ago - DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial - GlobeNewsWire
- 2 months ago - DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - DBV Technologies S.A. (DBVT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report - GlobeNewsWire
- 3 months ago - DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024 - GlobeNewsWire